Q3 FY26 results: Revenue up 17%, PAT up 35%, Rs 10 interim dividend declared

Pat Growth 25pctEbitda Margin ExpansionExceptional ItemEmphasis Of MatterResults View source PDF Explain this filing

APOLLOHOSP · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+4.0%Reaction day

₹7216.00

prior close

₹7405.00

announcement price

After-mkt

timing

Nifty 100market · index membership as recorded later (tracked since Jun 2026)+0.2%+3.9% vs market

Hospital peers, median of 23sector+1.3%+2.7% vs sector

On the reaction day the stock moved 3.9 pts more than Nifty 100 and 2.7 pts more than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+1.6

10m

+2.7

15m

+2.7

30m

+2.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+4.0+0.2+3.9+1.3+2.7

Next day

+4.5-0.4+4.9+2.3+2.2

+4.3-1.7+6.0+0.8+3.5

+5.1-0.9+6.0+1.1+4.0

+5.0-0.7+5.7+2.0+3.0

+5.9-0.3+6.2+2.5+3.4

+5.2-1.3+6.4-0.3+5.5

15d

+8.0-4.3+12.3-2.0+10.0

+6.7-7.4+14.2-2.6+9.3

+4.1-7.4+11.4-1.9+6.0

+12.0-6.7+18.6+9.0+3.0

UpDownMarket · Nifty 100Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Apollo Hospitals Q3FY26 consolidated results: Revenue at Rs 6,477 crore, up 17% YoY. EBITDA at Rs 965 crore, up 27%. PAT at Rs 502 crore, up 35%. YTD revenue grew 15% to Rs 18,623 crore, PAT up 34% to Rs 1,412 crore. All 3 verticals - healthcare services, retail health, and digital health/pharmacy - posted strong growth. Launched 250-bed quaternary hospital in Pune. Board declared Rs 10 per share interim dividend, record date 16 Feb 2026. Demerger of pharmacy business into Apollo Healthtech continues.

Likely market impact

Strong broad-based growth with margin expansion across verticals. Interim dividend of Rs 10 per share. HealthCo demerger progressing to NCLT.